167 related articles for article (PubMed ID: 9113118)
1. Tropisetron (Navoban): just another "setron"?
Aapro MS
Semin Oncol; 1994 Oct; 21(5 Suppl 9):1-2. PubMed ID: 9113118
[No Abstract] [Full Text] [Related]
2. [Experience with the clinical use of navoban].
Voznyĭ EK; Dobrovol'skaia NI; Volkova LA
Vopr Onkol; 1995; 41(1):70-1. PubMed ID: 7667947
[No Abstract] [Full Text] [Related]
3. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L
Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
[TBL] [Abstract][Full Text] [Related]
4. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
5. [Navoban--the new 5HT3-antagonist].
Internist (Berl); 1994 May; 35(5 Suppl):1-8. PubMed ID: 9209536
[No Abstract] [Full Text] [Related]
6. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
Madej G; Krzakowski M; Pawinski A; Lasota W; Rogowski W; Skoneczna I
Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119
[TBL] [Abstract][Full Text] [Related]
7. Prevention of emesis by tropisetron (Navoban) in children receiving cytotoxic therapy for solid malignancies.
Otten J; Hachimi-Idrissi S; Balduck N; Maurus R
Semin Oncol; 1994 Oct; 21(5 Suppl 9):17-9. PubMed ID: 9113122
[TBL] [Abstract][Full Text] [Related]
8. Dose comparison of tropisetron (Navoban) 5 mg and 10 mg orally in the prophylaxis of dacarbazine-induced nausea and emesis.
Garbe C; Drechsler S; Fiedler H; Tilgen W; Landthaler M; Schroeder K; Kuehne KH; Faerber L
Semin Oncol; 1994 Oct; 21(5 Suppl 9):12-6. PubMed ID: 9113121
[TBL] [Abstract][Full Text] [Related]
9. Tropisetron and the 5-HT3 Antiemetics in Perspective. Proceedings of an international symposium. Vienna, Austria, October 2, 1992.
Ann Oncol; 1993; 4 Suppl 3():1-47. PubMed ID: 8103353
[No Abstract] [Full Text] [Related]
10. Mechanisms and management of nausea and emesis.
Dicato M
Oncology; 1996 Jun; 53 Suppl 1():1-3. PubMed ID: 8692544
[No Abstract] [Full Text] [Related]
11. Efficacy of tropisetron (Navoban) in controlling emesis induced in children by anti-cancer therapy.
Rosso P; Cordero di Montezemolo L; Vivenza C; Nasi C; Tonello M; Valle P; Madon E
Tumori; 1994 Dec; 80(6):459-63. PubMed ID: 7900236
[TBL] [Abstract][Full Text] [Related]
12. Nausea and vomiting associated with cancer chemotherapy: drug management in theory and in practice.
Antonarakis ES; Hain RD
Arch Dis Child; 2004 Sep; 89(9):877-80. PubMed ID: 15321871
[TBL] [Abstract][Full Text] [Related]
13. Tropisetron in the prevention of acute and delayed nausea and vomiting over six courses of emetogenic chemotherapy.
Bleiberg H; Hulstaert F; Buyse M; De Keyser P
Anticancer Drugs; 1998 Oct; 9(9):773-7. PubMed ID: 9840722
[TBL] [Abstract][Full Text] [Related]
14. Always more "setrons": how many do we need?
Aapro MS
Support Care Cancer; 1997 Jan; 5(1):1-2. PubMed ID: 9010981
[No Abstract] [Full Text] [Related]
15. Tropisetron in the control of nausea and vomiting induced by combined cancer chemotherapy in children.
Gershanovich M; Kolygin B; Pirgach N
Ann Oncol; 1993; 4 Suppl 3():35-7. PubMed ID: 8363998
[TBL] [Abstract][Full Text] [Related]
16. Update on the management of chemotherapy-related nausea and vomiting: an emphasis on the new class of agents--neurokinin-1 receptor antagonists.
Gralla R
Clin Adv Hematol Oncol; 2006 Jul; 4(7):507-8. PubMed ID: 17147235
[No Abstract] [Full Text] [Related]
17. Control of nausea and vomiting by Navoban (tropisetron) in 131 children receiving cytotoxic chemotherapy.
Benoit Y; Hulstaert F; Vermylen C; Sariban E; Hoyoux C; Uyttebroeck A; Otten J; Laureys G; De Kerpel I; Nortier D
Anticancer Drugs; 1995 Feb; 6 Suppl 1():9-14. PubMed ID: 7749170
[TBL] [Abstract][Full Text] [Related]
18. Current issues in the management of nausea and vomiting.
Gralla RJ
Ann Oncol; 1993; 4 Suppl 3():3-7. PubMed ID: 8363996
[TBL] [Abstract][Full Text] [Related]
19. Fighting nausea in the '90s: more and better anti-emetics can help.
Saphir A
J Natl Cancer Inst; 1997 Sep; 89(17):1252-5. PubMed ID: 9293911
[No Abstract] [Full Text] [Related]
20. [The antiemetic action of tropisetron (Navoban) in the cytostatic treatment of neoplastic diseases].
Buiuc AI; Găleşanu MR
Rev Med Chir Soc Med Nat Iasi; 1996; 100(3-4):160-4. PubMed ID: 9455457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
